Integrated BioPharma, Inc.: Integrated BioPharma Announces Change in Directors

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board

Related Keywords

United States ,Ukraine ,America ,Dina Masi ,Christina Kay ,Damon Desantis ,Riva Sheppard ,Carl Desantis ,Biopharma Inc ,Celsius Holding Inc ,Rexall Sundown Nutritional Company ,Company Board Of Directors ,Executives Officers Of The Company ,Nasdaq ,Integrated Biopharma ,Classi Director ,Co Chief Executives Officers ,North America ,Celsius Holding ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Integrated ,Iopharma ,Nnounces ,Change ,Directors ,